Biyong Ren
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Biological effects on breast cancer cells of strong terahertz waves from a terahertz free-electron laser.
Journal: Electromagnetic biology and medicine
Published: October 21, 2025
High-Dose Aumolertinib for Untreated EGFR-Variant Non-Small Cell Lung Cancer With Brain Metastases: The ACHIEVE Phase 2 Nonrandomized Clinical Trial.
Journal: JAMA oncology
Published: June 26, 2025
Biological Effects of Intense Terahertz Waves at 2.88 THz on Breast Cancer and Melanoma Cells.
Journal: Journal of biophotonics
Published: June 17, 2025
Efficacy and safety analysis of atezolizumab continuation beyond progression in extensive-stage small cell lung cancer.
Journal: Clinical and experimental medicine
Published: December 03, 2024
Phase 2 dose-ranging study to evaluate the efficacy and safety of liposomal irinotecan (LY01610) as a second-line treatment for patients with relapsed small cell lung cancer.
Journal: EClinicalMedicine
Published: March 16, 2024
Validation of different personalized risk models of chemotherapy-induced nausea and vomiting: results of a randomized, double-blind, phase III trial of fosaprepitant for cancer patients treated with high-dose cisplatin.
Journal: Cancer communications (London, England)
Published: April 23, 2022
Whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases: a multicenter, open-label, randomized, controlled phase III trial.
Journal: Neuro-oncology
Published: December 17, 2020
Efficacy of Anlotinib for the Treatment of Angiosarcoma of the Face and Neck: A Case Report.
Journal: Frontiers in oncology
Published: August 20, 2020
Fosaprepitant versus aprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: a multicenter, randomized, double-blind, double-simulated, positive-controlled phase III trial.
Journal: Annals of translational medicine
Published: April 21, 2020
Biosimilar candidate IBI305 plus paclitaxel/carboplatin for the treatment of non-squamous non-small cell lung cancer.
Journal: Translational lung cancer research
Published: February 04, 2020
Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 05, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026